Tirzepatide is a dual-agonist targeting GLP-1 and GIP receptors, while retatrutide is a triple-agonist that also activates the glucagon receptor
At NY Drip Lounge, this therapy is provided under expert supervision to help ensure safety, effectiveness, and personalized care
Understanding Metabolic Regulation and Its Influence on Cell Physiology
Key Benefits: Improves the appearance of skin texture: visibly smooths the appearance of cellulite and dimpled skin on the thighs, buttocks, and abdomen
ARSYNL Rxs GLP-1 care model is built around privacy, discretion, and licensed medical review
Eligibility criteria mirror the FDA-approved indications: a BMI of 30 kg/m or higher (or 95th percentile for adolescents), or a BMI of 27 kg/m or higher with at least one weight-related health condition